Use of voriconazole in treatment of Scedosporium apiospermum infection: case report

J Clin Microbiol. 1998 May;36(5):1436-8. doi: 10.1128/JCM.36.5.1436-1438.1998.

Abstract

We report a case of disseminated Scedosporium apiospermum infection in a neutropenic patient with acute myeloid leukemia. Due to progression of the mycosis after 7 days of amphotericin B lipid complex therapy and to high susceptibility of the mold to voriconazole in vitro, the patient was treated with intravenous voriconazole. After a few days of therapy, fever disappeared and skin lesions improved. However, the patient died after 1 month due to intestinal bleeding. Despite a negative outcome, this case seems to indicate a promising role for voriconazole in the treatment of S. apiospermum infections.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Antifungal Agents / therapeutic use*
  • Dermatomycoses / drug therapy*
  • Dermatomycoses / etiology
  • Fatal Outcome
  • Humans
  • Leukemia, Myeloid / complications
  • Male
  • Pseudallescheria*
  • Pyrimidines / therapeutic use*
  • Triazoles / therapeutic use*
  • Voriconazole

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • Voriconazole